Entera Bio (ENTX) Income Statement (2021 - 2026)
Income Statement report data from Mar 31, 2021 to Mar 31, 2026 for Entera Bio (ENTX).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||
Total Revenue | - | - | - | - | 40K (-50.00%) | 80K (+100.00%) | 40K (-33.33%) | 60K | - | - | - | - | - | 10K (0.00%) | 10K (-75.00%) | 40K (-42.86%) | 70K (-58.82%) | 170K (+21.43%) | 140K (+27.27%) | 110K (-31.25%) | 160K |
Cost Of Revenue | - | - | - | - | 40K (-50.00%) | 80K (+100.00%) | 40K (-20.00%) | 50K | - | - | - | - | - | 10K (0.00%) | 10K (-66.67%) | 30K (-40.00%) | 50K (-64.29%) | 140K (+100.00%) | 70K (-30.00%) | 100K (+42.86%) | 70K |
Costof Goods And Services Sold | - | - | - | - | 40K (-50.00%) | 80K (+100.00%) | 40K (-20.00%) | 50K | - | - | - | - | - | 10K (0.00%) | 10K (-66.67%) | 30K (-40.00%) | 50K (-64.29%) | 140K (+100.00%) | 70K (-30.00%) | 100K (+42.86%) | 70K |
Gross Profit | - | - | - | - | - | - | - | 10K | - | - | - | - | - | 10K | - | 10K (0.00%) | 10K (-66.67%) | 30K (-62.50%) | 80K (+700.00%) | 10K (-87.50%) | 80K |
Operating Expenses | |||||||||||||||||||||
Research And Development | 2.25M (+30.81%) | 1.72M (+4.88%) | 1.64M (+7.89%) | 1.52M (+35.71%) | 1.12M (-6.67%) | 1.20M (-18.92%) | 1.48M (+35.78%) | 1.09M (+47.30%) | 740K (-26.00%) | 1.00M (-27.01%) | 1.37M (+13.22%) | 1.21M (+30.11%) | 930K (-31.11%) | 1.35M (-4.26%) | 1.41M (+1.44%) | 1.39M (-17.75%) | 1.69M (-36.23%) | 2.65M (+49.72%) | 1.77M (+43.90%) | 1.23M (+9.82%) | 1.12M |
Selling General And Administrative | 130K (+160.00%) | 50K (-58.33%) | 120K (+20.00%) | 100K (-16.67%) | 120K | -1.18M | 60K (-53.85%) | 130K (-90.23%) | 1.33M (+37.11%) | 970K (-5.83%) | 1.03M (-9.65%) | 1.14M (-11.63%) | 1.29M (-25.86%) | 1.74M (+19.18%) | 1.46M (-22.34%) | 1.88M (-13.36%) | 2.17M (+46.62%) | 1.48M (-3.90%) | 1.54M (+13.24%) | 1.36M (+3.82%) | 1.31M |
Operating Expenses | 3.54M (+16.45%) | 3.04M (-6.75%) | 3.26M (+22.10%) | 2.67M (+4.30%) | 2.56M (+9.40%) | 2.34M (-22.52%) | 3.02M (+39.17%) | 2.17M (+5.34%) | 2.06M (+5.10%) | 1.96M (-17.99%) | 2.39M (+2.58%) | 2.33M (+5.43%) | 2.21M (-28.01%) | 3.07M (+6.97%) | 2.87M (-11.96%) | 3.26M (-15.32%) | 3.85M (-6.55%) | 4.12M (+24.85%) | 3.30M (+27.91%) | 2.58M (+6.61%) | 2.42M |
Depreciation And Amortization | 10K (-50.00%) | 20K | - | - | 10K (-66.67%) | 30K | - | - | 10K (-75.00%) | 40K | - | - | 10K (-80.00%) | 50K | - | - | 20K (-50.00%) | 40K | - | - | 10K |
Operating Income | |||||||||||||||||||||
Operating Income | -3.54M (+16.45%) | -3.04M (-6.75%) | -3.26M (+22.10%) | -2.67M (+4.30%) | -2.56M (+9.40%) | -2.34M (-22.52%) | -3.02M (+39.81%) | -2.16M (+4.85%) | -2.06M (+5.10%) | -1.96M (-17.99%) | -2.39M (+2.58%) | -2.33M (+5.43%) | -2.21M (-28.01%) | -3.07M (+7.34%) | -2.86M (-12.00%) | -3.25M (-15.14%) | -3.83M (-6.36%) | -4.09M (+27.02%) | -3.22M (+25.29%) | -2.57M (+9.83%) | -2.34M |
Ebit | -3.54M (+16.45%) | -3.04M (-6.75%) | -3.26M (+22.10%) | -2.67M (+4.30%) | -2.56M (+9.40%) | -2.34M (-22.52%) | -3.02M (+39.81%) | -2.16M (+4.85%) | -2.06M (+5.10%) | -1.96M (-17.99%) | -2.39M (+2.58%) | -2.33M (+5.43%) | -2.21M (-28.01%) | -3.07M (+7.34%) | -2.86M (-12.00%) | -3.25M (-15.14%) | -3.83M (-6.36%) | -4.09M (+27.02%) | -3.22M (+25.29%) | -2.57M (+9.83%) | -2.34M |
EBITDA | -3.53M (+14.24%) | -3.09M (-3.44%) | -3.20M (+20.30%) | -2.66M (+3.91%) | -2.56M (+10.34%) | -2.32M (-23.18%) | -3.02M (+41.12%) | -2.14M (+4.39%) | -2.05M (+4.59%) | -1.96M (-16.60%) | -2.35M (+0.86%) | -2.33M (+5.91%) | -2.20M (-28.34%) | -3.07M (+6.97%) | -2.87M (-10.03%) | -3.19M (-16.49%) | -3.82M (-4.74%) | -4.01M (+24.15%) | -3.23M (+24.71%) | -2.59M (+11.16%) | -2.33M |
Other Income / Expenses | |||||||||||||||||||||
Other Non Operating Income | 30K (-66.67%) | 90K (+50.00%) | 60K (+500.00%) | 10K | - | 60K | - | 20K (-60.00%) | 50K (+66.67%) | 30K (-25.00%) | 40K (+300.00%) | 10K (-50.00%) | 20K (-75.00%) | 80K | -10.00K | 60K (+50.00%) | 40K | -30.00K (+200.00%) | -10.00K (-50.00%) | -20.00K | 30K |
Net Income | |||||||||||||||||||||
Income Before Tax | - | -11.44M | - | - | - | -6.51M (+115.56%) | -3.02M | - | - | -1.99M (-15.32%) | -2.35M (+0.86%) | -2.33M (+6.39%) | -2.19M (-28.90%) | -3.08M (+7.32%) | -2.87M (-10.03%) | -3.19M (-15.83%) | -3.79M (-7.79%) | -4.11M (+27.24%) | -3.23M (+24.71%) | -2.59M (+12.12%) | -2.31M |
Income Tax Expense | - | - | - | - | - | 10K | - | - | - | - | 30K | - | - | -50.00K | 190K | - | -10.00K (0.00%) | -10.00K (0.00%) | -10.00K (-50.00%) | -20.00K (+100.00%) | -10.00K |
Net Income From Continuing Operations | -3.50M (+15.89%) | -3.02M (-5.63%) | -3.20M (+20.30%) | -2.66M (+3.50%) | -2.57M (+8.90%) | -2.36M (-21.85%) | -3.02M (+41.12%) | -2.14M (+5.94%) | -2.02M (+1.51%) | -1.99M (-16.39%) | -2.38M (+2.15%) | -2.33M (+6.39%) | -2.19M (-27.72%) | -3.03M (-1.30%) | -3.07M (-3.46%) | -3.18M (-15.87%) | -3.78M (-7.80%) | -4.10M (+27.73%) | -3.21M (+24.42%) | -2.58M (+12.17%) | -2.30M |
Net Income | -3.50M (+15.89%) | -3.02M (-5.63%) | -3.20M (+20.30%) | -2.66M (+3.50%) | -2.57M (+8.90%) | -2.36M (-21.85%) | -3.02M (+41.12%) | -2.14M (+5.94%) | -2.02M (+1.51%) | -1.99M (-16.39%) | -2.38M (+2.15%) | -2.33M (+6.39%) | -2.19M (-27.72%) | -3.03M (-1.30%) | -3.07M (-3.46%) | -3.18M (-15.87%) | -3.78M (-7.80%) | -4.10M (+27.73%) | -3.21M (+24.42%) | -2.58M (+12.17%) | -2.30M |